Rallybio Corporation (RLYB) has a market capitalization of $43.8M and trades at $8.28. The 52-week range is 1.76-11.49.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -5.2, Earnings Per Share (EPS) of $-1.59, annual revenue of $858K.
The stock has a beta of -1.20, operates in the Healthcare sector.
